These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19522741)

  • 1. Aspirin reduces the prothrombotic activity of C-reactive protein.
    Grad E; Golomb M; Koroukhov N; Lawson JA; Lotan C; Fitzgerald GA; Danenberg HD
    J Thromb Haemost; 2009 Aug; 7(8):1393-400. PubMed ID: 19522741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of thromboxane receptor in C-reactive protein-induced thrombosis.
    Grad E; Pachino RM; FitzGerald GA; Danenberg HD
    Arterioscler Thromb Vasc Biol; 2012 Oct; 32(10):2468-74. PubMed ID: 22879580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neointimal formation is reduced after arterial injury in human crp transgenic mice.
    Danenberg HD; Grad E; Swaminathan RV; Chen Z; Seifert P; Szalai AJ; Lotan C; Simon DI; Edelman ER
    Atherosclerosis; 2008 Nov; 201(1):85-91. PubMed ID: 18358478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased thrombosis after arterial injury in human C-reactive protein-transgenic mice.
    Danenberg HD; Szalai AJ; Swaminathan RV; Peng L; Chen Z; Seifert P; Fay WP; Simon DI; Edelman ER
    Circulation; 2003 Aug; 108(5):512-5. PubMed ID: 12874178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein decreases prostacyclin release from human aortic endothelial cells.
    Venugopal SK; Devaraj S; Jialal I
    Circulation; 2003 Oct; 108(14):1676-8. PubMed ID: 14504187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transgenic expression of human C-reactive protein suppresses endothelial nitric oxide synthase expression and bioactivity after vascular injury.
    Grad E; Golomb M; Mor-Yosef I; Koroukhov N; Lotan C; Edelman ER; Danenberg HD
    Am J Physiol Heart Circ Physiol; 2007 Jul; 293(1):H489-95. PubMed ID: 17369452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a thromboxane A2-receptor antagonist, a thromboxane synthetase inhibitor and aspirin on prostaglandin I2 production in endothelium-intact and -injured aorta of guinea pigs.
    Higo K; Karasawa A
    Jpn J Pharmacol; 1994 Dec; 66(4):471-9. PubMed ID: 7723224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired endothelial function in C-reactive protein overexpressing mice.
    Teoh H; Quan A; Lovren F; Wang G; Tirgari S; Szmitko PE; Szalai AJ; Ward ME; Verma S
    Atherosclerosis; 2008 Dec; 201(2):318-25. PubMed ID: 18433756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ASP6537, a novel highly selective cyclooxygenase-1 inhibitor, exerts potent antithrombotic effect without "aspirin dilemma".
    Sakata C; Kawasaki T; Kato Y; Abe M; Suzuki K; Ohmiya M; Funatsu T; Morita Y; Okada M
    Thromb Res; 2013 Jul; 132(1):56-62. PubMed ID: 23522855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-reactive protein-mediated vascular injury requires complement.
    Hage FG; Oparil S; Xing D; Chen YF; McCrory MA; Szalai AJ
    Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1189-95. PubMed ID: 20339115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of prostacyclin in the cardiovascular response to thromboxane A2.
    Cheng Y; Austin SC; Rocca B; Koller BH; Coffman TM; Grosser T; Lawson JA; FitzGerald GA
    Science; 2002 Apr; 296(5567):539-41. PubMed ID: 11964481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estradiol selectively stimulates endothelial prostacyclin production through estrogen receptor-{alpha}.
    Sobrino A; Oviedo PJ; Novella S; Laguna-Fernandez A; Bueno C; García-Pérez MA; Tarín JJ; Cano A; Hermenegildo C
    J Mol Endocrinol; 2010 Apr; 44(4):237-46. PubMed ID: 20110403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of endothelial cyclooxygenase-2 and prostanoid synthesis by platelets. Role of thromboxane A2.
    Caughey GE; Cleland LG; Gamble JR; James MJ
    J Biol Chem; 2001 Oct; 276(41):37839-45. PubMed ID: 11483590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen treatment abrogates neointima formation in human C-reactive protein transgenic mice.
    Wang D; Oparil S; Chen YF; McCrory MA; Skibinski GA; Feng W; Szalai AJ
    Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2094-9. PubMed ID: 16051879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential involvement of serotonin 2A/C and thromboxane A2/prostanoid receptors in high- vs. low-shear rate arterial thrombosis in rabbits.
    Valentin JP; Vieu S; Bertolino F; Fauré P; John GW
    J Pharmacol Exp Ther; 1997 Feb; 280(2):761-9. PubMed ID: 9023289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of cyclooxygenase (COX)-1 and COX-2 in prostanoid production by human endothelial cells: selective up-regulation of prostacyclin synthesis by COX-2.
    Caughey GE; Cleland LG; Penglis PS; Gamble JR; James MJ
    J Immunol; 2001 Sep; 167(5):2831-8. PubMed ID: 11509629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells: role of protein kinase C and reactive oxygen species.
    Cosentino F; Eto M; De Paolis P; van der Loo B; Bachschmid M; Ullrich V; Kouroedov A; Delli Gatti C; Joch H; Volpe M; Lüscher TF
    Circulation; 2003 Feb; 107(7):1017-23. PubMed ID: 12600916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective inhibition of prostacyclin synthase activity by rofecoxib.
    Griffoni C; Spisni E; Strillacci A; Toni M; Bachschmid MM; Tomasi V
    J Cell Mol Med; 2007; 11(2):327-38. PubMed ID: 17488481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelium-dependent contraction: The non-classical action of endothelial prostacyclin, its underlying mechanisms, and implications.
    Liu B; Zhou Y
    FASEB J; 2021 Sep; 35(9):e21877. PubMed ID: 34449098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the dual TP receptor antagonist and thromboxane synthase inhibitor EV-077 on human endothelial and vascular smooth muscle cells.
    Petri MH; Tellier C; Michiels C; Ellertsen I; Dogné JM; Bäck M
    Biochem Biophys Res Commun; 2013 Nov; 441(2):393-8. PubMed ID: 24161392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.